Abstract YO19
Case summary
Recent studies have shown evidence of cross-lineage transdifferentiation of B-cell lymphomas, such as low-grade FL and CLL/SLL,to histiocytic and dendritic cell sarcomas, but the clonal relationship between the 2 neoplasms is still unclear. Here, we report the morphologic, molecular and cytogenetic analysis of a unique case of CLL/SLL associated with indeterminate dendritic cell tumor and possibly a hybrid lymphodendritic cell neoplasm , using immunohistochemistry, electron microscopy, in situ hybridization and FISH.A 48-year-old Chinese female presented with left upper neck swelling. Blood examination revealed lymphocytosis.Microscopic examinations showed the lymph node has effaced architecture, and has a very complicated, variegated appearance with three distinct components. The first component contained small lymphocytes, prolymphocytes and paraimmunoblasts, showing typical CLL/SLL immunophenotype, with ZAP-70 positive and EBV negative. The second component contained nodular aggregates of large pink cells with abundant eosinophilic cytoplasm and deeply grooved nuclei, showing immunophenotype of indeterminate dendritic cell tumor and EBV positive. The third component had intermediate morphologic features between lymphoid cells and dendritic cells characteristics, a bit reminiscent of anaplastic large cell lymphoma, but expressed some B cell markers PAX5 and OCT2, as well as dendritic/histiocytic markers CD1a, CD68, Fascin, and Lysozyme, and was diffusely EBV positive. Electron microscopy revealed the cells in the third component had short and thick bulges like dendritic cell. FISH analysis using CLL probes showed identical deletion 17p13.1, deletion 11q22.3, and deletion 13q14.3 in all 3 components. Sharing of CD5 and OCT2 expression and identical cytogenetic abnormality in all 3 components suggest a common clonal origin for the three components.Our study provides evidence for transdifferentiation of CLL/SLL to dendritic cell tumor possibly via the intermediate linklymplymphodendritic cell neoplasm, and suggests that EBV may play a role in this phenomenon.
Clinical trial identification
Editorial acknowledgement
Resources from the same session
133P - Prognostic and predictive factors from the phase III CELESTIAL trial of cabozantinib (C) versus placebo (P) in previously treated advanced hepatocellular carcinoma (aHCC)
Presenter: Thomas Yau
Session: Poster display session
Resources:
Abstract
134P - Identification, development and validation of a circulating miRNA-based diagnostic signature for early detection of gastric cancer
Presenter: Daisuke Izumi
Session: Poster display session
Resources:
Abstract
135P - The promising key genes associated with tumour microenvironment and prognosis of hepatocellular carcinoma
Presenter: Jing Fang
Session: Poster display session
Resources:
Abstract
136P - Helicobacter pylori-positive gastric diffuse large B-cell lymphoma: A subset with distinct prognostic features
Presenter: Yuan Cheng
Session: Poster display session
Resources:
Abstract
137P - Significant benefit of pyrotinib combined with SHR6390 in patients with multiline-resistant HER2-positive advanced gastric cancer
Presenter: Zuhua Chen
Session: Poster display session
Resources:
Abstract
138P - Incidence of supracarinal lymph node positivity in operated cases of total esophagectomy: Short term results from a tertiary cancer centre
Presenter: Akhil Palod
Session: Poster display session
Resources:
Abstract
139P - Prognostic usefulness of advanced lung cancer inflammation index in locally-advanced pancreatic carcinoma patients treated with radical chemoradiotherapy
Presenter: Ayberk Besen
Session: Poster display session
Resources:
Abstract
140P - Pancreaticoduodenectomy versus combined neoadjuvant chemotherapy and pancreaticoduodenectomy: Survival patterns among patients with stage II & III periampullary carcinoma
Presenter: Mai Abdelkader
Session: Poster display session
Resources:
Abstract
141P - A 13-gene signature of DNA repair predicts prognosis in gastric cancer patients
Presenter: Jinjia Chang
Session: Poster display session
Resources:
Abstract
142P - Relation between Interleukin -4 (590C/T) gene polymorphism and hepatocellular carcinoma risk in HBV and HCV patients
Presenter: Suzy Gohar
Session: Poster display session
Resources:
Abstract